{"id":"https://openalex.org/W4394533648","doi":"https://doi.org/10.6084/m9.figshare.3573510","title":"Synergistic effects of eIF4A and MEK inhibitors on proliferation of NRAS-mutant melanoma cell lines","display_name":"Synergistic effects of eIF4A and MEK inhibitors on proliferation of NRAS-mutant melanoma cell lines","publication_year":2016,"publication_date":"2016-01-01","ids":{"openalex":"https://openalex.org/W4394533648","doi":"https://doi.org/10.6084/m9.figshare.3573510"},"language":"en","primary_location":{"id":"pmh:oai:figshare.com:article/3573510","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/Synergistic_effects_of_eIF4A_and_MEK_inhibitors_on_proliferation_of_NRAS-mutant_melanoma_cell_lines/3573510","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"},"volume":null,"type":"dataset","is_traditional":false,"indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://figshare.com/articles/dataset/Synergistic_effects_of_eIF4A_and_MEK_inhibitors_on_proliferation_of_NRAS-mutant_melanoma_cell_lines/3573510","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059950593","display_name":"H\u00e9l\u00e8ne Malka-Mahieu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Malka-Mahieu, H\u00e9l\u00e8ne","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000095429","display_name":"Isabelle Girault","orcid":"https://orcid.org/0000-0002-9587-5197","observed_orcids":["https://orcid.org/0000-0002-9587-5197"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Girault, Isabelle","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074354589","display_name":"Margot Rubington","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rubington, Margot","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085304862","display_name":"Melissa Leriche","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Leriche, Melissa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000420531","display_name":"Caroline Welsch","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Welsch, Caroline","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077195590","display_name":"Nyam Kamsu-Kom","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nyam Kamsu-Kom","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078586677","display_name":"Qian Zhao","orcid":"https://orcid.org/0000-0001-5092-8702","observed_orcids":["https://orcid.org/0000-0001-5092-8702"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhao, Qian","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071118882","display_name":"Laurent D\u00e9saubry","orcid":"https://orcid.org/0000-0002-1192-2970","observed_orcids":["https://orcid.org/0000-0002-1192-2970"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Desaubry, Laurent","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081632204","display_name":"St\u00e9phan Vagner","orcid":"https://orcid.org/0000-0003-1452-7164","observed_orcids":["https://orcid.org/0000-0003-1452-7164"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vagner, St\u00e9phan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5100713900","display_name":"Caroline Robert","orcid":"https://orcid.org/0000-0002-9493-0238","observed_orcids":["https://orcid.org/0000-0002-9493-0238"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert, Caroline","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10521","display_name":"RNA and protein synthesis mechanisms","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nras-mutation","display_name":"NRAS mutation","score":0.7900000214576721},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9959999918937683},{"id":"https://openalex.org/keywords/eif4a","display_name":"eIF4A","score":0.8939999938011169},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.9369999766349792},{"id":"https://openalex.org/keywords/eif4f","display_name":"eIF4F","score":0.8849999904632568},{"id":"https://openalex.org/keywords/eif4e","display_name":"eIF4E","score":0.6880000233650208},{"id":"https://openalex.org/keywords/eif4g","display_name":"eIF4G","score":0.9480000138282776},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.6499999761581421},{"id":"https://openalex.org/keywords/synergistic-drug-combination","display_name":"synergistic drug combination","score":0.7450000047683716},{"id":"https://openalex.org/keywords/flavaglines","display_name":"flavaglines","score":0.7269999980926514},{"id":"https://openalex.org/keywords/rocaglates","display_name":"rocaglates","score":0.781000018119812},{"id":"https://openalex.org/keywords/ras-mapk-pathway","display_name":"RAS/MAPK pathway","score":0.8700000047683716},{"id":"https://openalex.org/keywords/pi3k-akt-mtor-pathway","display_name":"PI3K/AKT/mTOR pathway","score":0.9729999899864197},{"id":"https://openalex.org/keywords/translation-initiation","display_name":"translation initiation","score":0.5759999752044678},{"id":"https://openalex.org/keywords/cell-proliferation","display_name":"cell proliferation","score":0.6660000085830688}],"concepts":[{"id":"https://openalex.org/C21790070","wikidata":"https://www.wikidata.org/wiki/Q18030215","display_name":"Neuroblastoma RAS viral oncogene homolog","level":5,"score":0.8452379107475281},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.6531456708908081},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.6399580240249634},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5503538846969604},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.4219181537628174},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3188769221305847},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.23143300414085388},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1520015001296997},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.06294676661491394},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.054554879665374756}],"mesh":[],"locations_count":5,"locations":[{"id":"pmh:oai:figshare.com:article/3573510","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/Synergistic_effects_of_eIF4A_and_MEK_inhibitors_on_proliferation_of_NRAS-mutant_melanoma_cell_lines/3573510","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"},{"id":"doi:10.6084/m9.figshare.3573510","doi":"https://doi.org/10.6084/m9.figshare.3573510","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.3573510","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Dataset"},{"id":"doi:10.6084/m9.figshare.3573510.v1","doi":"https://doi.org/10.6084/m9.figshare.3573510.v1","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.3573510.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Other"},{"id":"doi:10.6084/m9.figshare.3573510.v2","doi":"https://doi.org/10.6084/m9.figshare.3573510.v2","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.3573510.v2","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Dataset"},{"id":"doi:10.6084/m9.figshare.3573510.v3","doi":"https://doi.org/10.6084/m9.figshare.3573510.v3","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.3573510.v3","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Dataset"}],"best_oa_location":{"id":"pmh:oai:figshare.com:article/3573510","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/Synergistic_effects_of_eIF4A_and_MEK_inhibitors_on_proliferation_of_NRAS-mutant_melanoma_cell_lines/3573510","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"},"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2612169864","https://openalex.org/W7065596665","https://openalex.org/W2031134972","https://openalex.org/W4234523903","https://openalex.org/W1496715045","https://openalex.org/W7025153339","https://openalex.org/W2066715392","https://openalex.org/W7147405934","https://openalex.org/W2152171197","https://openalex.org/W2065620201"],"abstract_inverted_index":{"Activating":[0],"mutations":[1],"of":[2,20,41,73,100,109,112,137,151,159],"the":[3,22,32,39,42,49,53,58,65,70,110,115,120,134,138,148,152,160],"NRAS":[4],"(neuroblastoma":[5],"rat":[6],"sarcoma":[7],"viral":[8],"oncogene)":[9],"protein":[10,25,56,117],"kinase,":[11],"present":[12],"in":[13,36,86,95,141],"many":[14],"cancers,":[15],"induce":[16],"a":[17,156],"constitutive":[18],"activation":[19],"both":[21],"RAS-RAF-MEK-ERK":[23],"mitogen-activated":[24],"kinase":[26],"(MAPK)":[27],"signal":[28],"transduction":[29],"pathway":[30],"and":[31,57,90],"PI(3)K-AKT-mTOR,":[33],"pathway.":[34],"This":[35],"turn":[37],"regulates":[38],"formation":[40,136],"eIF4F":[43,122,139,153],"eukaryotic":[44],"translation":[45],"initiation":[46],"complex,":[47,123,154],"comprising":[48],"eIF4E":[50,113],"cap-binding":[51],"protein,":[52],"eIF4G":[54],"scaffolding":[55],"eIF4A":[59,149],"RNA":[60],"helicase,":[61],"which":[62],"binds":[63],"to":[64,114,129,167],"7-methylguanylate":[66],"cap":[67],"(m(7)G)":[68],"at":[69],"5\u2019":[71],"end":[72],"messenger":[74],"RNAs.":[75],"Small":[76],"molecules":[77],"targeting":[78],"MEK":[79,81,166],"(MEKi:":[80],"inhibitors)":[82],"have":[83,125],"demonstrated":[84],"activity":[85],"NRAS-mutant":[87,143,169],"cell":[88,144,171],"lines":[89],"tumours,":[91],"but":[92],"resistance":[93,128],"sets":[94],"most":[96],"cases":[97],"within":[98],"months":[99],"treatment.":[101],"Using":[102],"proximity":[103],"ligation":[104],"assays,":[105],"that":[106,127],"allows":[107],"visualization":[108],"binding":[111],"scaffold":[116],"eIF4G,":[118],"generating":[119],"active":[121],"we":[124],"found":[126],"MEKi":[130],"is":[131],"associated":[132],"with":[133,155,164],"persistent":[135],"complex":[140],"MEKi-treated":[142],"lines.":[145,172],"Furthermore,":[146],"inhibiting":[147,165],"component":[150],"small":[157],"molecule":[158],"flavagline/rocaglate":[161],"family,":[162],"synergizes":[163],"kill":[168],"cancer":[170]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2024-04-08T00:00:00"}